大摩：同程旅行(00780)第三季业绩略胜预期目标价29港元维持“增持”评级

26 11 月, 2025

One Min Read

7 Views

Last Update: 26 11 月, 2025

Written By

Other Articles

Previous

国投证券：首予先瑞达医疗-B(06669)“买入”评级全球领先的创新型医疗器械

Next

港股异动 | 君实生物(01877)再涨超5% 特瑞普利单抗皮下注射III期临床达主要终点后续拟申报上市

Related Posts

先消灭低价股！

1 Min Read

假期市场思考：A股还是美股？

1 Min Read

香港证券两日成交额破百亿！港股仍有市场？

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept